FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sven Skouby

Research Profile

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Johannes Bitzer; Teresa Bombas; Mitchell Creinin; Philip D Darney; Kristina Gemzell Danielsson; Bruno Imthurn; Jeffrey T Jensen; Andrew M Kaunitz; Ali Kubba; Medard M Lech; Diana Mansour; Gabriele Merki; Thomas Rabe; Katarina Sedlecki; David Serfaty; Jacques Seydoux; Lee P Shulman; Regine Sitruk-Ware; Sven O Skouby; Anne Szarewski; James Trussell; Lisa Ferreira Vicente; Jean-Jacques Amy; Rob Beerthuizen; Martin Birkhäuser; Carolyn Westhoff
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
Ellen W Freeman; Gary Grubb; Uriel Halbreich; Sebastian Mirkin; Andrea J Rapkin; Sven O Skouby; Lynne Smith; Ginger D Constantine
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome.
Johannes J Sidelmann; Sven O Skouby; Frank Vitzthum; Ulrich Winkler; Jørgen Gram; Cornelis Kluft; Herbert Schwarz; Jørgen Jespersen
Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sven Skouby (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Johannes Bitzer; Teresa Bombas; Mitchell Creinin; Philip D Darney; Kristina Gemzell Danielsson; Bruno Imthurn; Jeffrey T Jensen; Andrew M Kaunitz; Ali Kubba; Medard M Lech; Diana Mansour; Gabriele Merki; Thomas Rabe; Katarina Sedlecki; David Serfaty; Jacques Seydoux; Lee P Shulman; Regine Sitruk-Ware; Sven O Skouby; Anne Szarewski; James Trussell; Lisa Ferreira Vicente; Jean-Jacques Amy; Rob Beerthuizen; Martin Birkhäuser; Carolyn Westhoff
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2013;18(3):143-7.
2012: Ellen W Freeman; Gary Grubb; Uriel Halbreich; Sebastian Mirkin; Andrea J Rapkin; Sven O Skouby; Lynne Smith; Ginger D Constantine
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome.
Contraception 2012;85(5):437-45.
2011: Johannes J Sidelmann; Sven O Skouby; Frank Vitzthum; Ulrich Winkler; Jørgen Gram; Cornelis Kluft; Herbert Schwarz; Jørgen Jespersen
Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo.
Thrombosis research 2011;128(5):e67-72.
2011: Line Cleemann; Arieh Cohen; Anna-Maria Andersson; Kirsten Holm; Hanne Kobbernagel; Bent Kristensen; Sven O Skouby; Heidi Smedegaard; Claus Gravholt
Normal tempo of bone formation in Turner syndrome despite signs of accelerated bone resorption.
Hormone research in pædiatrics 2011;76(3):193-201.
2010: Sven O Skouby
Hormonal contraception in obesity, the metabolic syndrome, and diabetes.
Annals of the New York Academy of Sciences 2010;1205():240-4.
2010: J J Sidelmann; Sven O Skouby; F Vitzthum; H Schwarz; Jørgen Jespersen
Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women.
Climacteric : the journal of the International Menopause Society 2010;13(4):340-6.
2010: Line Klingen Haugaard; Henrik Vestergaard; Sven O Skouby
[Polycystic ovary syndrome and comorbidity].
Ugeskrift for laeger 2010;172(3):199-202.
2009: M C Lutterodt; K P Sørensen; K B Larsen; Sven O Skouby; Claus Yding Andersen; Anne Grete Byskov
The number of oogonia and somatic cells in the human female embryo and fetus in relation to whether or not exposed to maternal cigarette smoking.
Human reproduction (Oxford, England) 2009;24(10):2558-66.
2009: Melissa Lutterodt; Anne Grete Byskov; Sven O Skouby; Ann Tabor; Claus Yding Andersen
Anti-Müllerian hormone in pregnant women in relation to other hormones, fetal sex and in circulation of second trimester fetuses.
Reproductive biomedicine online 2009;18(5):694-9.
2009: Sven O Skouby; Joergen Jespersen
Progestins in HRT: sufferance or desire?
Maturitas 2009;62(4):371-5.
2008: Sven O Skouby
Genital cancer and oral contraceptives. The good news!
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2008;13(4):327-9.
2008: Sven O Skouby; Johannes J Sidelmann; Lisbeth Nilas; J Gram; Jørgen Jespersen
The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
Climacteric : the journal of the International Menopause Society 2008;11(6):489-97.
2007: David F Archer; Susan Hendrix; Alex Ferenczy; Juan Felix; J Chris Gallagher; Janice Rymer; Sven O Skouby; Wil den Hollander; Victoria Stathopoulos; Frans A Helmond
Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women.
Fertility and sterility 2007;88(4):866-78.
2007: Sven O Skouby; Johannes J Sidelmann; Lisbeth Nilas; Jørgen Jespersen
A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
Human reproduction (Oxford, England) 2007;22(4):1186-91.
2007: David F Archer; Susan Hendrix; J Chris Gallagher; Janice Rymer; Sven O Skouby; Alex Ferenczy; Wil den Hollander; Victoria Stathopoulos; Frans A Helmond
Endometrial effects of tibolone.
The Journal of clinical endocrinology and metabolism 2007;92(3):911-8.
2007: anne Gompel; David Barlow; Serge Rozenberg; Sven O Skouby
The EMAS 2006/2007 update on clinical recommendations on postmenopausal hormone therapy.
Maturitas 2007;56(2):227-9.
2006: Peter Alexandersen; Laszlo Tanko; Yu Z Bagger; Jørgen Jespersen; Sven O Skouby; Claus Christiansen
Associations between aortic calcification and components of body composition in elderly men.
Obesity (Silver Spring, Md.) 2006;14(9):1571-8.
2006: anne Gompel; David Barlow; Serge Rozenberg; Sven O Skouby
Updating the EMAS 2004/2005 clinical recommendations on postmenopausal therapy following the recent publications: WHI and Nurses' Health Study.
Maturitas 2006;55(1):1-4.
2006: Moniek P M de Maat; Else Marie Bladbjerg; Cornelis Kluft; U H Winkler; H Rekers; Sven O Skouby; Jørgen Jespersen
Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosis.
Human reproduction (Oxford, England) 2006;21(6):1473-6.
2005: Jørgen Jespersen; Jan Endrikat; Bernd Düsterberg; Werner Schmidt; Christoph Gerlinger; Jens Wessel; Johannes J Sidelmann; Sven O Skouby
A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.
Contraception 2005;72(2):98-104.
2005: Sven O Skouby; Farook Al-Azzawi; David Barlow; Joaquin Calaf-Alsina Erdogan Ertüngealp; anne Gompel; Alessandra Graziottin; Decebal Hudita; Amos Pines; Serge Rozenberg; Göran Samsioe; John Stevenson
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Maturitas 2005;51(1):8-14.
2005: Sven O Skouby; Jan Endrikat; Bernd Düsterberg; Werner Schmidt; Christoph Gerlinger; Jens Wessel; Henri Goldstein; Jørgen Jespersen
A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Contraception 2005;71(2):111-7.
2004: Henry Burger; David Archer; David Barlow; Martin H Birkhäuser; Joaquim Calaf-Alsina; Marco Gambacciani; Andrea Genazzani; Peyman Hadji; Ole-Erik Iversen; Herbert Kuhl; Rogerio A Lobo; Thierry Maudelonde; Manuel Neves e Castro; Morris Notelovitz; Santiago Palacios; Tomasz Paszkowski; Eitan Peer; Amos Pines; Göran Samsioe; John Stevenson; Sven O Skouby; David W Sturdee; Tobie de Villiers; Malcolm Whitehead; Olavi Ylikorkala
Practical recommendations for hormone replacement therapy in the peri- and postmenopause.
Climacteric : the journal of the International Menopause Society 2004;7(2):210-6.
2004: Sven O Skouby
Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries.
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2004;9(2):57-68.
2004: Sven O Skouby; David Barlow; Göran Samsioe; anne Gompel; Amos Pines; Farook Al-Azzawi; Alessandra Graziottin; Decebal Hudita; Serge Rozenberg
Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.
Maturitas 2004;48(1):19-25.
2004: Markku Ahotupa; Ilkka Rauramo; Tommi Vasankari; Sven O Skouby; Tiina Hakonen
Estrogen replacement therapy in combination with continuous intrauterine progestin administration reduces the amount of circulating oxidized LDL in postmenopausal women: dependence on the dose of progestin.
Annals of medicine 2004;36(4):278-84.
2003: Sven O Skouby
[Hormone therapy and cardiovascular disease after menopause. Myths and realities].
Ugeskrift for laeger 2003;165(41):3907.
2003: Peter Alexandersen; Jens Haarbo; Pieter Zandberg; Jørgen Jespersen; Sven O Skouby; Claus Christiansen
Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study.
Human reproduction (Oxford, England) 2003;18(7):1395-403.
2003: Johannes J Sidelmann; Jørgen Jespersen; Lars F Andersen; Sven O Skouby
Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study.
BJOG : an international journal of obstetrics and gynaecology 2003;110(6):541-7.
2002: Sven O Skouby; Jørgen Jespersen; Cornelis Kluft; Gordon D O Lowe; Lucy Norris; Göran Samsioe; John Stevenson
On the route to combined evidence from OC and HRT/ERT.
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2002;7(4):185-98.
2002: Else Marie Bladbjerg; Sven O Skouby; Lars F Andersen; Jørgen Jespersen
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.
Human reproduction (Oxford, England) 2002;17(12):3235-41.
2002: Sven O Skouby
Consequenses for HRT following the HERS II and WHI reports: the primum non nocere is important, but translation into quo vadis is even more essential.
Acta obstetricia et gynecologica Scandinavica 2002;81(9):793-8.
2002: Sven O Skouby; Charlotte Wilken-Jensen; Jørgen Jespersen; Anette Tønnes Pedersen; Bent S Ottesen
[Postmenopausal hormone replacement therapy--is there a cause of worry?].
Ugeskrift for laeger 2002;164(34):3974-5.
2002: Anette Tønnes Pedersen; Sven O Skouby; Jørgen Jespersen; Bent S Ottesen
[Hormone replacement therapy in menopause and cardiovascular disease].
Ugeskrift for laeger 2002;164(34):3973-4.
2002: Marla Chellakooty; Lillian Skibsted; Sven O Skouby; Anna-Maria Andersson; Jørgen Holm Petersen; Katharina M Main; Niels E Skakkebaek; Anders Juul
Longitudinal study of serum placental GH in 455 normal pregnancies: correlation to gestational age, fetal gender, and weight.
The Journal of clinical endocrinology and metabolism 2002;87(6):2734-9.
2002: Sven O Skouby; Jørgen Gram; Lars F Andersen; Johannes J Sidelmann; Kresten R Petersen; Jørgen Jespersen
Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
American journal of obstetrics and gynecology 2002;186(5):969-77.
2000: Sven O Skouby
The rationale for a wider range of progestogens.
Climacteric : the journal of the International Menopause Society 2000;3 Suppl 2():14-20.
1999: Kresten R Petersen; E Christiansen; S Madsbad; Sven O Skouby; Lars F Andersen; Jørgen Jespersen
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.
Contraception 1999;60(6):337-44.
1999: Morten Beck Sørensen; Sven O Skouby; Bent S Ottesen
[Post-menopausal hormone substitution and ischemic heart disease].
Ugeskrift for laeger 1999;161(5):607-8.
1999: Lars F Andersen; Jørgen Gram; Sven O Skouby; Jørgen Jespersen
Effects of hormone replacement therapy on hemostatic cardiovascular risk factors.
American journal of obstetrics and gynecology 1999;180(2 Pt 1):283-9.
1998: Sven O Skouby
Oral contraceptives and venous thrombosis: end of the debate?
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 1998;3(2):59-64.
1996: K R Petersen; L L Kjems; Sven O Skouby; Lars F Andersen; Jørgen Jespersen
No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
Metabolism: clinical and experimental 1996;45(7):833-7.
1996: K R Petersen; Sven O Skouby; P V Jepsen; A B Haaber
[Diabetes regulation and oral contraceptives. Lipoporotein metabolism in women with insulin dependent diabetes mellitus using oral contraceptives].
Ugeskrift for laeger 1996;158(17):2388-92.
1996: K R Petersen; Sven O Skouby; Jørgen Jespersen
Contraception guidance in women with pre-existing disturbances in carbohydrate metabolism.
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 1996;1(1):53-9.
1995: K R Petersen; Sven O Skouby; P Vedel; A B Haaber
Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipoprotein metabolism.
Diabetes care 1995;18(6):800-6.
1995: K R Petersen; Sven O Skouby; Jørgen Jespersen
Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
International journal of fertility and menopausal studies 1995;40 Suppl 2():105-11.
1994: K R Petersen; Sven O Skouby; J Sidelmann; Jørgen Jespersen
Assessment of endothelial function during oral contraception in women with insulin-dependent diabetes mellitus.
Metabolism: clinical and experimental 1994;43(11):1379-83.
1994: K R Petersen; Sven O Skouby; J Sidelmann; L Mølsted-Pedersen; Jørgen Jespersen
Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus.
American journal of obstetrics and gynecology 1994;171(2):400-5.
1994: K R Petersen; Sven O Skouby; J Sidelmann; Jørgen Jespersen
[Hemostatic balance during treatment with the newest contraceptives].
Ugeskrift for laeger 1994;156(2):187-90.
1993: P V Bagger; V Andersen; B Baslund; B Beck; H Hove; M Høier-Madsen; J Petersen; John Philip; O Schaadt; Sven O Skouby
Anti-cardiolipin antibodies (IgG and IgA) in women with recurrent fetal loss correlate to clinical and serological characteristics of SLE.
Acta obstetricia et gynecologica Scandinavica 1993;72(6):465-9.
1993: Sven O Skouby; Jørgen Jespersen; K P Petersen
[Metabolic effects of oral contraceptives].
Advances in contraception : the official journal of the Society for the Advancement of Contraception 1993;9 Suppl 1():49-58.
1993: K R Petersen; J Sidelmann; Sven O Skouby; Jørgen Jespersen
Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
American journal of obstetrics and gynecology 1993;168(1 Pt 1):32-8.
1991: K R Petersen; L Brooks; B Jacobsen; Sven O Skouby
Intrauterine devices in nulliparous women.
Advances in contraception : the official journal of the Society for the Advancement of Contraception 1991;7(4):333-8.
1991: L Mølsted-Pedersen; Sven O Skouby; P Damm
Preconception counseling and contraception after gestational diabetes.
Diabetes 1991;40 Suppl 2():147-50.
1991: K R Petersen; Sven O Skouby; R G Pedersen
Desogestrel and gestodene in oral contraceptives: 12 months' assessment of carbohydrate and lipoprotein metabolism.
Obstetrics and gynecology 1991;78(4):666-72.
1991: Sven O Skouby; L Mølsted-Pedersen; K R Petersen
Contraception for women with diabetes: an update.
Baillière's clinical obstetrics and gynaecology 1991;5(2):493-503.
1991: T Agner; P Damm; Sven O Skouby
Menstrual cycle and skin reactivity.
Journal of the American Academy of Dermatology 1991;24(4):566-70.
1991: P V Bagger; Sven O Skouby
[Anti-phospholipid antibodies and habitual abortion].
Ugeskrift for laeger 1991;153(13):944-6.
1991: Sven O Skouby; K R Petersen
Clinical experience with the recently developed progestogens.
International journal of fertility 1991;36 Suppl 1():32-7.
1990: Jørgen Jespersen; K R Petersen; Sven O Skouby
Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
American journal of obstetrics and gynecology 1990;163(1 Pt 2):396-403.
1990: Sven O Skouby; O Andersen; K R Petersen; L Mølsted-Pedersen; C Kühl
Mechanism of action of oral contraceptives on carbohydrate metabolism at the cellular level.
American journal of obstetrics and gynecology 1990;163(1 Pt 2):343-8.
1988: Sven O Skouby
Oral contraceptives: hormonal dose and effects on carbohydrate metabolism.
Maturitas 1988;Suppl 1():111-5.
1988: K Rubeck Petersen; Sven O Skouby; A Dreisler; C Kühl; B Svenstrup
Comparative trial of the effects on glucose tolerance and lipoprotein metabolism of two new oral contraceptives containing gestoden and desogestrel.
Acta obstetricia et gynecologica Scandinavica 1988;67(1):37-41.
1987: K R Petersen; Sven O Skouby; A Dreisler; C Kühl
[Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism].
Ugeskrift for laeger 1987;149(24):1614-6.
1987: Sven O Skouby
Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.
International journal of fertility 1987;32 Suppl():45-8.
1986: Sven O Skouby; L Mølsted-Pedersen; C Kühl; P Bennet
Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progestogen profiles.
Fertility and sterility 1986;46(5):858-64.
1986: Sven O Skouby; L Mølsted-Pedersen; C Kühl
Contraception in diabetic women.
Acta endocrinologica. Supplementum 1986;277():125-9.
1985: Sven O Skouby; C Kühl; L Mølsted-Pedersen; K Petersen; M S Christensen
Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes.
American journal of obstetrics and gynecology 1985;153(5):495-500.
1985: Sven O Skouby; B M Jensen; C Kühl; L Mølsted-Pedersen; B Svenstrup; J Nielsen
Hormonal contraception in diabetic women: acceptability and influence on diabetes control and ovarian function of a nonalkylated estrogen/progestogen compound.
Contraception 1985;32(1):23-31.
1984: Sven O Skouby; L Mølsted-Pedersen; A Kosonen
Consequences of intrauterine contraception in diabetic women.
Fertility and sterility 1984;42(4):568-72.
1982: Sven O Skouby; L Mølsted-Pedersen
Intrauterine contraceptive devices for diabetics.
Lancet 1982;1(8278):968.
1982: Sven O Skouby; L Mølsted-Pedersen; C Kühl
Low dosage oral contraception in women with previous gestational diabetes.
Obstetrics and gynecology 1982;59(3):325-8.